MDxHealth SA (NAS:MDXH)

Preliminary Q2 2025 MDxHealth SA Earnings Call Transcript

Aug 5, 2025 / 08:30 PM GMT

Release Date Price: $2.49 (+0.81%)

Transcript

Key Points

Positve

MDxHealth SA (MDXH) reported a Q2 2025 revenue of $26.6 million, marking a 20% growth and the 17th consecutive quarter of 20% or greater revenue growth.
The company achieved its first quarter of adjusted EBITDA profitability with $1.4 million, as anticipated.
MDxHealth SA (MDXH) announced a pending acquisition of the Exo DX business, expected to accelerate top-line revenue growth and provide immediate accretion to EBITDA operating profitability.
The company has doubled its revenue over the past three years without expanding its sales team, demonstrating efficient sales execution.
Gross margins improved to 66% from 60% in the prior year, attributed to test mix and operational efficiencies.

Negative

The operating loss for the quarter was $1.9 million, although it declined by 74% compared to the previous year.
Net loss decreased by 36% to $7.4 million, indicating ongoing financial challenges despite improvements.
The market shift away from the Select test due to the requirement for a digital rectal exam and the rise of home testing kits poses a challenge.
The acquisition of Exo DX involves integration complexities, including potential structural changes and the absorption of new sales reps.
The company has not yet provided formal guidance for 2026, creating uncertainty about future financial performance.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MDXH.OQ - MDxHealth SA
Preliminary Q2 2025 MDxHealth SA Earnings Call
Aug 05, 2025 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day ladies and gentlemen, and welcome to the MDX Health second quarter of 2025 earnings conference call.

All participants will be lit in only mode.

The question and answer session will follow the formal presentation.

If anyone should require operator assistance during the conference, please press the star key and then 0 on your telephone keypad.

Please note that this event is being recorded.

I would now like to turn the conference over to John Francis of Life Site Advisors. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
-------------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.